Paola Secchiero
Department of Morphology and Embryology
University of Ferrara
Via Fossato di Mortara 66
44100 Ferrara
Italy
Name/email consistency: high
- Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesis. Secchiero, P., Zauli, G. Curr. Opin. Hematol. (2008)
- Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells. Secchiero, P., Corallini, F., Rimondi, E., Chiaruttini, C., di Iasio, M.G., Rustighi, A., Del Sal, G., Zauli, G. Blood (2008)
- Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells. Secchiero, P., Melloni, E., Tiribelli, M., Gonelli, A., Zauli, G. J. Leukoc. Biol. (2008)
- Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70. Secchiero, P., di Iasio, M.G., Gonelli, A., Barbarotto, E., Melloni, E., Tiribelli, M., Chiaruttini, C., Zauli, G. J. Cell. Physiol. (2007)
- Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Secchiero, P., Zerbinati, C., di Iasio, M.G., Melloni, E., Tiribelli, M., Grill, V., Zauli, G. Curr. Drug Metab. (2007)
- Antiangiogenic activity of the MDM2 antagonist nutlin-3. Secchiero, P., Corallini, F., Gonelli, A., Dell'Eva, R., Vitale, M., Capitani, S., Albini, A., Zauli, G. Circ. Res. (2007)
- Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero, P., Corallini, F., Barbarotto, E., Melloni, E., di Iasio, M.G., Tiribelli, M., Zauli, G. J. Cell. Physiol. (2006)
- Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL). Secchiero, P., Barbarotto, E., Tiribelli, M., Zerbinati, C., di Iasio, M.G., Gonelli, A., Cavazzini, F., Campioni, D., Fanin, R., Cuneo, A., Zauli, G. Blood (2006)
- TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release. Secchiero, P., Corallini, F., di Iasio, M.G., Gonelli, A., Barbarotto, E., Zauli, G. Blood (2005)
- Aberrant expression of TRAIL in B chronic lymphocytic leukemia (B-CLL) cells. Secchiero, P., Tiribelli, M., Barbarotto, E., Celeghini, C., Michelutti, A., Masolini, P., Fanin, R., Zauli, G. J. Cell. Physiol. (2005)
- Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. Secchiero, P., Barbarotto, E., Gonelli, A., Tiribelli, M., Zerbinati, C., Celeghini, C., Agostinelli, C., Pileri, S.A., Zauli, G. Am. J. Pathol. (2005)
- TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Secchiero, P., Melloni, E., Heikinheimo, M., Mannisto, S., Di Pietro, R., Iacone, A., Zauli, G. Blood (2004)
- TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells. Secchiero, P., Zerbinati, C., Rimondi, E., Corallini, F., Milani, D., Grill, V., Forti, G., Capitani, S., Zauli, G. Cell. Mol. Life Sci. (2004)
- TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Secchiero, P., Gonelli, A., Carnevale, E., Milani, D., Pandolfi, A., Zella, D., Zauli, G. Circulation (2003)
- Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NF-kappaB-dependent maturation of normal and leukemic myeloid cells. Secchiero, P., Milani, D., Gonelli, A., Melloni, E., Campioni, D., Gibellini, D., Capitani, S., Zauli, G. J. Leukoc. Biol. (2003)
- Tumor necrosis factor-related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway. Secchiero, P., Gonelli, A., Mirandola, P., Melloni, E., Zamai, L., Celeghini, C., Milani, D., Zauli, G. Blood (2002)
- Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies. Secchiero, P., Gonelli, A., Celeghini, C., Mirandola, P., Guidotti, L., Visani, G., Capitani, S., Zauli, G. Blood (2001)